Post Archive by Year

As year-end international travel increases, various real-time data sources are available to help individuals plan their upcoming trips.
Research suggests that approximately 1.4 billion passengers are expected to fly internationally in 2025, with around 92% of Americans intending to travel this year.
Furthermore, last-minute travelers often postpone about 18% of their vaccinations due to a lack of time before departure. The U.S. CDC notes that this is concerning, as most vaccinations require approximately two weeks for protection to become effective.

The global cholera situation is worsening and presents a significant public health challenge in several regions monitored by the World Health Organization (WHO).
As of late August 2025, cholera outbreaks are resurging in various countries, including some that had not reported significant case numbers in years.
According to a recent WHO report, between January and August 17, 2025, there were a total of 409,222 cases of cholera and acute watery diarrhea, resulting in 4,738 deaths worldwide. Notably, six of the 31 affected countries reported case fatality rates exceeding 1%.

The Pan American Health Organization (PAHO) has called for enhanced surveillance, improved clinical management, and effective vector control to tackle localized chikungunya outbreaks in various countries throughout the Americas.
As of August 28, 2025, the simultaneous circulation of arboviruses, such as chikungunya, dengue, and Zika, raises the risk of outbreaks, severe complications, and fatalities among vulnerable populations.

The American Journal of Infection Control (AJIC) recently published an analysis on vaccine hesitancy and mixed media messaging.
On August 26, 2025, a new analysis of Google News reports, focusing on the measles outbreak in the United States centered in western Texas, reveals that non-mainstream outlets published more credentialed content.

 Pfizer Inc. and BioNTech SE today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for the companies' LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA) for use in adults aged 65 years and older.

A new program in the United Kingdom will evaluate how wastewater monitoring could be used to detect a broader range of dangerous pathogens.
Announced by the UK Health Security Agency (UKHSA) on August 26, 2025, using £1.3 million of investment from the UK Integrated Security Fund, the project will assess the use of cutting-edge technologies to improve the UK's ability to detect and identify the genetic material of various viruses in wastewater, tracking how the amount of virus detected changes over time.